The drug will be manufactured at the group’s formulation manufacturing facility at Moraiya, Ahmedabad, India
A First of its Kind Initiative in Mahbubnagar District for Medical Officers, ANM, Anganwadi workers for prevention of Thalassemia and Sickle Cell anemia as part of Antenatal screening of pregnant women project
APAC to see a reduction in imported surgical robotics
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
Under the soon to be launched Heal in India initiative, India aims to provide its health infrastructure for patients abroad and make it a global hub for medical and value-based healthcare for patients from across the world
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
The cardiomyopathies market in the 68M is set to grow at a CAGR of 12.1%
The implementing agency of PMBJP has invited online applications for opening of new Jan Aushadhi Kendras in 651 districts of different States/UTs
Exceeding the target of 1.50 lakh Ayushman Bharat - Health & Wellness Centres (AB-HWC) by 31 December, 2022, more than 1.54 lakh Sub Health Centres and Primary Health Centres have been transformed as AB-HWCs
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
Subscribe To Our Newsletter & Stay Updated
